Concord Medical Services Holdings Ltd (CCM) — Institutional Holders, Q2 2026

7 institutional investment managers reported a CCM position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $170.6K. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.

CCM in Q2 2026: what funds did

Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.

New positions

3

Added to

0

Trimmed

2

Sold out

0

Biggest buyers

  1. SmartHarvest PortfoliosNew · +13,912 sh+$65.7K
  2. CITADEL ADVISORSNew · +10,543 sh+$49.8K
  3. JONES FINANCIAL COMPANIES LLLPNew · +10 sh+$47.00

Biggest sellers

  1. SUSQUEHANNA INTERNATIONAL GROUP, LLPTrimmed · -654 sh-$3.1K
  2. UBS Group AGTrimmed · -115 sh-$543.00

CCM 13F holders ranked 1–7 of 7

Institutional investors reporting a position in Concord Medical Services Holdings Ltd on SEC Form 13F-HR for Q2 2026, ranked by reported value.
InstitutionValueQoQ
SmartHarvest Portfolios#1 · 13,912 sh$65.7KNew
SUSQUEHANNA INTERNATIONAL GROUP, LLP#2 · 11,069 sh$52.2K-5.6%
CITADEL ADVISORS#3 · 10,543 sh$49.8KNew
UBS Group AG#4 · 500 sh$2.4K-18.7%
MORGAN STANLEY#5 · 100 sh$472.000.0%
JONES FINANCIAL COMPANIES LLLP#6 · 10 sh$47.00New
SBI Securities , Ltd.#7 · 4 sh$19.000.0%

Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.